Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

doi:10.1016/S0739-5930(10)79530-1

Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

D.M. Harnois

- 01 Jan 2010 -

Yearbook of Gastroenterology

- Vol. 2010, pp 233-234

About:

This article is published in Yearbook of Gastroenterology.The article was published on 2010-01-01. It has received 584 citations till now. The article focuses on the topics: Hepatitis C virus.

Citations

PDF

Open Access

More filters

Declining liver graft quality threatens the future of liver transplantation in the United States

Eric S. Orman, +6 more

TL;DR: The transplant community will need to accept inferior grafts and potentially worse posttransplant outcomes and/or develop new strategies for increasing organ donation and utilization in order to maintain the number of LTs at the current level.

...read moreread less

Journal ArticleDOI

Hepatitis C Virus (HCV) Prevalence and Risk of Unsafe Parenteral Practices in Derqui, Argentine

Jorge T Insua, +2 more

TL;DR: The epidemiology of Hepatitis C Virus infection is not well known in Argentina or Latin America and the Caribbean (LAC), and improved prevalence estimates and modeling attempts are ongoing.

...read moreread less

Journal Article

Nouveaux traitements de l’hépatite C : quelles cibles, quel calendrier?

Nicolas Goossens, +1 more

- 01 Jan 2011 -

Revue médicale suisse

TL;DR: Two new direct acting antivirals, that inhibit NS3/4A viral protease, will soon be available on the Swiss market: telaprevir and boceprevir, which increase the rate of sustained viral response, in HCV genotype 1 infected patients, when co administered with pegylated interferon and ribavirin.

...read moreread less

Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination With Sofosbuvir in Naive Subjects Infected With Hepatitis C Virus Genotype 1

Giuseppe Morelli, +12 more

TL;DR: The results provide valuable information regarding the safety, tolerability and efficacy of telaprevir combined with sofosbuvir as dual therapy in naïve noncirrhotic HCV genotype 1 infected patients.

...read moreread less

Journal ArticleDOI

Diabetes in treated hepatitis C infection: dodging the sweet sting

Victoria Harris, +1 more

- 27 May 2015 -

Diabetes management

TL;DR: This work has shown clear trends in overweight and obese patients towards a Mediterranean diet, and these trends are likely to continue to be sustained over the long-term.

...read moreread less

Collapse

References

PDF

Open Access

More filters

Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

Gary L. Davis, +4 more

- 01 Feb 2010 -

Gastroenterology

TL;DR: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.

...read moreread less